Cholesterol accumulation is increased in macrophages of phospholipid transfer protein-deficient mice: normalization by dietary alpha-tocopherol supplementation

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2407-12. doi: 10.1161/ATVBAHA.107.151753. Epub 2007 Aug 23.

Abstract

Objective: Phospholipid transfer protein (PLTP) is a multifunctional, extracellular lipid transport protein that plays a major role in lipoprotein metabolism and atherosclerosis. Recent in vivo studies suggested that unlike systemic PLTP, macrophage-derived PLTP would be antiatherogenic. The present study aimed at characterizing the atheroprotective properties of macrophage-derived PLTP.

Methods and results: Peritoneal macrophages were isolated from PLTP-deficient and wild-type mice and their biochemical characteristics were compared. It is shown that macrophages isolated from PLTP-deficient mice have increased basal cholesterol content and accumulate more cholesterol in the presence of LDL compared with wild-type cells. Cholesterol parameters in macrophages of PLTP-deficient mice were normalized by dietary alpha-tocopherol supplementation.

Conclusions: The antiatherogenic properties of macrophage-derived PLTP are related at least in part to its ability to reduce cholesterol accumulation in macrophages through changes in the alpha-tocopherol content and oxidative status of the cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholesterol / metabolism*
  • Dietary Supplements*
  • Lipoproteins, LDL / metabolism
  • Macrophages, Peritoneal* / drug effects
  • Macrophages, Peritoneal* / metabolism
  • Malondialdehyde / metabolism
  • Mice
  • Mice, Knockout
  • Phospholipid Transfer Proteins / deficiency*
  • Vitamins / pharmacology*
  • alpha-Tocopherol / pharmacology*

Substances

  • Lipoproteins, LDL
  • Phospholipid Transfer Proteins
  • Vitamins
  • acetyl-LDL
  • phospholipid transfer protein, mouse
  • Malondialdehyde
  • Cholesterol
  • alpha-Tocopherol